Patents for A61P 33 - Antiparasitic agents (21,787)
02/2008
02/14/2008US20080038283 Methods of Evaluating Efficacy of an Immune Response by Assesing Alpha-1 Integrin Expression
02/13/2008EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
02/13/2008EP1476752A4 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
02/13/2008EP1248646B1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
02/13/2008CN101124211A Antibiotic FKI-1778 and its production method
02/13/2008CN101120986A Body-clearing itching-relieving liquid
02/13/2008CN101120980A Umbilicus-applied medicine for treating children intestinal ascariasis
02/13/2008CN101120979A Internal-applied traditional Chinese medicine for treating taeniasis
02/13/2008CN101120966A Capsule medicine for treating intestinal ascariasis
02/13/2008CN101120956A Internal-applied traditional Chinese medicine for treating children intestinal ascariasis
02/13/2008CN101120952A Anti-coccidiosis microorganism preparation and manufacturing method
02/13/2008CN101120795A Medical food for treating intestinal ascariasis
02/13/2008CN101120659A Method for treating and preventing scuticociliatosis in fishes
02/12/2008CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them
02/07/2008WO2008015001A1 Rho/rock/p13/akt kinase inhibitors for the treatment of diseases associated with protozoan parasites
02/07/2008WO2007144487A3 Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses
02/07/2008US20080033003 Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
02/07/2008US20080031907 Cosmetic and pharmaceutical foam
02/07/2008US20080031903 Method of treating ocular infections
02/07/2008US20080031896 Hydrophilic eimeria polypeptide; genetic engineering; vaccine for the protection of poultry against Eimeria infection
02/07/2008US20080031878 Polypeptides for the Diagnosis and Therapy of Leishamaniasis
02/07/2008CA2659712A1 Rho/rock/p13/akt kinase inhibitors for the treatment of diseases associated with protozoan parasites
02/06/2008EP1883452A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone
02/06/2008CN101120004A 8a,9-dihydro-4ah-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
02/06/2008CN101116735A Chinese traditional medicine preparations for treating trichomonal vaginitis
02/06/2008CN101116703A Medicinal food for treating tapeworm disease
02/06/2008CN101116701A Chinese traditional medicine composition for treating trichomonal vaginitis
02/06/2008CN101116665A Malaria-resisting arteannuin naphthoquine compound composition
02/06/2008CN100366290C Coccidial vaccine and methods of making and using same
02/05/2008US7326774 Monoclonal antibody and nematode larval antigens
02/05/2008US7326696 Amino-methyl substituted tetracycline compounds
02/05/2008CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
02/05/2008CA2274556C Compositions for the systemic control of parasites of warm-blooded animals
01/2008
01/31/2008WO2008014431A2 Method of treating ocular infections
01/31/2008WO2008013773A2 Quinine products, method of manufacture, and method of use
01/31/2008WO2008013336A1 Pyripyropene derivatives and insecticidal compositions comprising them
01/31/2008WO2008013235A1 Method of removing parasites on body surface of fishes
01/31/2008WO2008012524A1 Substituted aniline derivatives
01/31/2008WO2007131488A3 Use of quinoline derivatives as anti-protozoal agent and in combination preparations
01/31/2008WO2006110814A3 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
01/31/2008US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes
01/31/2008US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same
01/31/2008US20080026990 18-Membered Nitrobenzyl- and Aminobenzyl-Substituted Cyclohexadepsipeptides for Controlling Endoparasites and a Process for Their Preparation
01/31/2008US20080026071 Microparticles for delivery of heterologous nucleic acids
01/31/2008US20080026011 Immunostimulatory nucleic acid molecules
01/31/2008US20080026010 Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
01/31/2008US20080026006 Pharmaceutical composition useful for vaccines
01/31/2008US20080025944 Combination Therapy for Immunostimulation
01/31/2008DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs
01/31/2008CA2658913A1 Substituted aniline derivatives
01/31/2008CA2658624A1 Pyridazine and pyrrole compounds, processes for obtaining them and applications thereof
01/30/2008CN101112408A Sustained-release ji chrysanthemum tablet and method for preparing the same
01/30/2008CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection
01/29/2008CA2398485C Azalide antibiotic compositions
01/24/2008WO2008010776A1 Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
01/24/2008WO2008010697A1 Curcumin-based drug for the treatment of parasitic infection caused by giardia lamblia
01/24/2008WO2008009894A2 Use of imino sugars in immunotherapy
01/24/2008WO2007132438A3 Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
01/24/2008US20080021110 Producing (-)-gossypol acetic acid co-crystals from (-)-gossypol acetone co-crystals, by substituting acetone in (-)-gossypol acetone co-crystals with acetic acid; use of gossypol acetic acid co-crystals and (-)-gossypol acetic acid co-crystals for inducing and for sensitizing cells to apoptosis
01/24/2008US20080021093 Oxidation process with enhanced safety useful in the manufacture of Moxidectin
01/24/2008US20080021073 Novel heterocyclic compounds
01/24/2008US20080019989 Immunity Adjuvant Containing a Complexed Metal Cation and Vaccine Containing Same
01/24/2008CA2777173A1 Improvement of the bioavailability of active substances having an amidine function in medicaments
01/23/2008EP1879656A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol
01/23/2008EP1879576A1 Use of a metal ion chelating agent for the treatment of animal and human parasites
01/23/2008EP1284725B1 Medicament for the treatment of diseases caused by parasitic protozoa
01/23/2008EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base
01/23/2008CN101108161A Compound three-segment pin of hydrochloric acid amodiaquine and artesunate
01/23/2008CN101108160A Three-segment pin compound of hydrochloric acid amodiaquine and dihydroartemisinin
01/17/2008WO2007125414A3 9a-substituted azalides for the tratment of malaria
01/17/2008WO2006056930A3 Novel 4 -aminopiperidine derivatives as plasmepsin ii inhibitors
01/17/2008US20080015169 Amino-methyl substituted tetracycline compounds
01/17/2008US20080014228 Solid form
01/17/2008US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
01/17/2008CA2635903A1 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
01/16/2008EP1877434A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
01/16/2008EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
01/16/2008EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors
01/16/2008EP1107969B1 Collections of compounds
01/16/2008CN101107255A Anthelmintic imidazol-thiazole derivatives
01/16/2008CN101107246A Anti-trypanosomiasis agent
01/16/2008CN101107002A Anthelmintic composition
01/16/2008CN101104071A Decoction medicine for treating qi stagnation and blood stasis type biliary ascariasis and preparation method
01/16/2008CN101104042A Decoction medicine for treating damp-heat type biliary ascariasis and and preparation method
01/16/2008CN101104038A Decoction medicine for treating liver qi stagnancy biliary ascariasis and preparation method
01/10/2008US20080008767 Methods And Compositions For Controlling Parasitic Infections Of Animals
01/10/2008CA2656617A1 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
01/10/2008CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
01/09/2008EP1874293A1 Association between ferroquine and an artemisinine derivative for treating malaria
01/09/2008EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels
01/09/2008CN101102785A Prevention of vertical endoparasite infections
01/09/2008CN101099795A Traditional Chinese medicine for treating trichmonas vaginalis
01/09/2008CN101099738A Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation
01/09/2008CN101099737A Medicine for treating trypanosome disease
01/09/2008CN100360665C I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
01/09/2008CN100360536C Novel compounds and uses thereof
01/09/2008CN100360127C Ornidazole effervescent tablet
01/08/2008US7317114 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities
01/08/2008US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 218